Leucine Rich Repeat Containing Protein 18 (LRRC18) Antibody (Biotin)
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Leucine Rich Repeat Containing Protein 18 (LRRC18) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx309415
tested applications
ELISA
Description
LRRC18 Antibody (Biotin) is a Rabbit Polyclonal against LRRC18 conjugated to Biotin.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Leucine Rich Repeat Containing Protein 18 (LRRC18) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Biotin |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q8N456 |
| Gene ID | 474354 |
| NCBI Accession | NP_001006940.3, NM_001006939.3 |
| Alias | LRRC18,UNQ9338/PRO34010 |
| Background | Antibody anti-LRRC18 |
| Status | RUO |
Descripción
LRRC18 is a lesser-characterized member of the LRRC family with suggested roles in immune responses and cellular signaling based on its expression in lymphoid tissues studies have identified LRRC18 as being involved in the regulation of T cell activation and differentiation as it interacts with key signaling pathways associated with immune synapse formation emerging evidence indicates its potential role in modulating inflammatory responses particularly through cytokine release and receptor crosstalk in immune cells its expression pattern suggests involvement in hematopoietic cell function and immune surveillance although its exact biological mechanisms remain to be fully characterized bioinformatics analyses suggest links to signal transduction and membrane trafficking processes LRRC18 may also contribute to tumor immunology by modulating immune cell infiltration and activity within the tumor microenvironment further studies are needed to define its interactions and assess its therapeutic potential in immunological diseases and cancer
Related Products
Leucine Rich Repeat Containing Protein 18 (LRRC18) Antibody
LRRC18 Antibody is a Rabbit Polyclonal against LRRC18.
Ver ProductoLeucine Rich Repeat Containing Protein 18 (LRRC18) Antibody (HRP)
LRRC18 Antibody (HRP) is a Rabbit Polyclonal against LRRC18 conjugated to HRP.
Ver Producto
Leucine Rich Repeat Containing Protein 18 (LRRC18) Antibody (FITC)
LRRC18 Antibody (FITC) is a Rabbit Polyclonal against LRRC18 conjugated to FITC.
Ver Producto